Findings

What do systematic reviews say?

62 questions · 64 findings · 10 reviews

No studies found 14 · 21.9%GRADE not reported 3 · 4.7%Very low 24 · 37.5%Low 15 · 23.4%Moderate 8 · 12.5%High 0 · 0%

Positive surgical margins MCID: 5% absolute difference · men (ages > 18 years) with clinically localized prostate cancer

Retzius‐sparing RALP may leads to higher positive surgical margins MCID: 5% absolute difference compared with standard RALP (low certainty).

1 finding from 1 review

Biochemical recurrence‐free survival · men (ages > 18 years) with clinically localized prostate cancer

It is very uncertain whether retzius‐sparing RALP changes biochemical recurrence‐free survival compared with standard RALP (very low certainty).

1 finding from 1 review